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ABSTRACT
BACKGROUND: Most policies in Nigeria are deliberate choices based on political mechanism, oversight, and lack of 
appropriate information. However in recent times there has been a global shift towards evidence based policy making. 
Thus Actors' views on evidence and their role in policy development appear critical to the use of evidence. 
 
OBJECTIVE: This study aimed to examine how actors' perception, roles and levels of power influenced Human Resources 
for Health policy development in Nigeria. 
METHOD: The research was conducted using a case study approach. Systematic reviews of relevant policy documents and 
reports, in-depth interviews of twelve respondents comprising government policymakers, academia, civil society 
organizations, health-workers and development partners were done. Interviews were analysed using NVivo 10 software 
for qualitative analysis. 
FINDINGS: Most respondents perceived evidence to be factual and concrete to support a given decision. The government 
policymakers wielded a high level of power and spearheaded the policy process. Development partners were major 
decision makers because they had financial and technical power. Civil society groups had the power of advocacy and 
generated evidence. The academia had medium power level of power and also generated evidence. 
CONCLUSION: The actors' with the highest level of power greatly influenced policy use and type of evidence used in 
formulating the Human Resources for Health policy. Stakeholders with coercive, financial or group power influenced the 
type of evidence finally used in formulating the Human Resources for Health policy.    
KEY WORDS: Human Resource for Health; Health policy making; Role of actors in policy making 
Original Article 
INTRODUCTION
he pattern and nature of actors 
Tinvolved in formulation of any policy or strategy inuence the policy 
1
making process and implementation .  
Differences in opinion of actors about a 
problem often result in divergent views on 
2.
how to solve the problem.  This is because 
political, nancial, authoritative, intellectual 
and intuitive factors all come into play, 
inadvertently determining the type of power 
and level of inuence actors have in order to 
sway the policy process to their own way of 
1
thinking. 
The documented process for policy making in 
Nigeria is unclear as it consists of political 
manoeuvres and interplay of actors with 
polit ical  debates which go on in an 
inconsistent manner until the policy is nally 
3,4developed.   Policy making in Nigeria, is the 
responsibility of the executive branch of 
government, while the legislative branch 
approves policies.  A centralized, top-down 
approach to policy making is used, restricting 
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policy-making to the upper echelons of the 
political and bureaucratic system. This small 
“circle" of people tend to make decisions 
4-6based on intuition and personal experiences.  
The use of evidence or the type of evidence 
usedin formulating policy is often skewed 
towards the members of the team with a high 
 6, 7
level of power.    
8,9Nigeria, with a population of over 170 million , 
has one of the largest Human Resource for 
Health(HRH)stocks in Africa with 30 doctors 
and 100 nurses per 100,000 population 
comparable to the sub-Saharan African 
average of 15 doctors and 72 nurses per 
10, 11100,000 population.  Despite this large 
number, the country still does not have 
enough health personnel to deliver effective 
10
health care services.   
The Nigerian HRH policy document was rst 
developed in 2006 following World Health 
reports devoted to addressing the global 
11 ,12HRH crisis  and low ranking of the 
13.
countries health system   The lack of 
evidence based health policies which will 
improve health outcomes have been 
identied as one of the reasons for weak 
health systems such that the incorporation of 
relevant high quality research evidence into 
policy-making has been outlined as a key 
s trategy to  improve heal th  systems 
worldwide and thus improve universal 
13-15access to health.
Actors' views on evidence and their roles in 
policy development are critical to the use of 
evidence to develop policy. Thus the aim of 
this study is to examine how different actors' 
perception of evidence and their roles in the 
policy development process have inuenced 
the use of evidence in development of the 
HRH policy. This information will enhance 




The study was undertaken in Nigeria, where 
provision of healthcare is a concurrent 
responsibility of the three tiers of government 
(Federal, State and Local government). The 
Federal Ministry of Health (FMoH) is 
responsible for policy and technical support 
to the overall health system; the State 
Ministries of Health (SMoH) are responsible 
for the provision of secondary healthcare 
services, regulation and technical support for 
primary healthcare services and the local 
governments are responsible for primary 
1health care services.  
This study was part of a larger retrospective 
qualitative study and employed a case study 
approach. Data was collected through a 
systematic review of relevant documents and 
in-depth interviews of key national and state 
level stakeholders involved in the HRH 
policy development. The respondents were 
categorized into various groups namely; 
policy makers, civil society organizations 
(CSOs), academia/researchers, development 
partners, media and health workers. The list 
of respondents to be interviewed was 
informed by a review of relevant published 
documents as well as anecdotal information 
from review of unpublished documents, and 
snowballing from previous respondents. A 
total of 12 stakeholders were eventually 
interviewed for this study. 
An interview guide was developed to elicit 
information on four thematic areas, derived 
from the study conceptual framework which 
was drawn from literature and adapted to 
guide understanding and assessment of role 
of evidence in health policy and strategy 
16development . The four thematic areas were 
Evidence (types and characteristics), policy 
development (stages and content), Context 
(level of power and position) and Policy 
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actors (roles and characteristics). For the 
purpose of this study policy development 
incorporates both the evidence generation 
and policy processes. Emphasis was laid on 
information on policy actors and evidence 
aspects.
The in-depth interviews were audio recorded 
and transcribed. Transcriptions were coded 
using Nvivo 10 qualitative analysis software 
and analysed by comparing with the ndings 
of the document reviews.  However, for this 
article; to fully understand actor roles in HRH 
policy, the Walt and Gilson policy triangle 
framework was be used. It places the actors in 
the middle of the triangle of context, policy 
content and policy process and allows for 
exploration of actor interests, level of power 
and position with regards to the policy; from 
the agenda setting through to the policy 
formulation, implementation and evaluation 
17.
Ethical considerations 
Ethical approval for the study was obtained 
from the Ethics Board of the University of 
Nigeria Teaching Hospital Enugu.  
RESULTS
Actors involved in policy process 
Four broad groups of actors were very 
involved in the policy processes namely: 
 i. Government policy makers, ii. Civil society 
organizations (CSO), iii. Academia and iv) 
Development partners (DP).  Groups 
infrequently mentioned were health workers, 
legislators and private health service 
providers.  Actors played various roles in 
developing the HRH policy based on their 
individual understanding of evidence, their 
ideologies and the evidence considered most 
important for policy formulation.  
A cross cutting look at the key actors involved 
in both HRH policy and evidence process 
identied different actors' groups. These 
actors included top policy elites such as the 
government policy makers and minister of 
health, senior civil servants, development 
partners, regulatory bodies, civil society 
organizat ions,  and other  individual 
consultants. The actors specically identied 
in the policy process were Minister of Health, 
Directors in the FMoH, Director planning, 
research and statistics (DPRS) of various 
SMoHs,  a  t echnica l  work ing  group 
comprising; professional health groups and 
academia. Also involved were the members 
of the National Council on Health and the 
Medical and Dental Council of Nigeria 
(MDCN), CSO's and Development partners 
such as Partnerships for Transforming Health 
Systems Phase 2 (PATHS2), World Health 
Organisation (WHO) and State Accountability 
and Voice Initiative (SAVI) played a huge 
role. Members of the academia and other 
research networks participated also in the 
policy process. However, involvement of 
actors during the two phases of policy 
development varied. 
Some actors were specically identied as 
participating in the evidence gathering 
process; Government policy makers, Heads 
of service and directors in SMoH, Primary 
health care boards, and health training 
institutions, MDCN, development partners 
and individual consultants consisting of 
researchers and the academia. A larger 
representation of actors were involved in the 
policy process than in the evidence process. 
The identied gap suggests that there was a 
narrower actor network and participation 
during evidence process than there was 
during policy process, though important 
actors were still left out in both processes. 
However, there was a clear cut presence of the 
international actors in both processes, some of 
which together with the FMoH spearheaded 
the policy. The directorate of planning, 
research and at all levels of the government 
were involved. Although consultants were 
hired to generate the evidence, it would have 
been more meaningful if a network of some 
researchers were involved in the evidence 
process. Unfortunately, the media also did 
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not participate in either of the processes. This 
implied that there was poor dissemination of 
the policy before it was launched. Excerpts 
from the interviews buttress this point.
“You know in the ministry of health, there are 
about ve directors, and a permanent secretary. 
All of them were involved. The commissioner was 
also involved. There were some technical 
assistants from WHO, HERFON, and other 
partners. All presidents of professional bodies were 
all there. There were people from health training 
institutions and research organizations”– (HRH 
Policy maker 5). “We did not see any member of 
the media during all these meetings. They were 
only present when we had concluded the policy 
and were launching” (Policy Maker)
“Consultants were hired to do the assessment but 
they worked through the ministry of health. The 
director of planning, research and statistics was 
i n v o l v e d .  S o m e t i m e s ,  t h e  d i r e c t o r  o f 
administration, director of public health, nursing, 
and principal and provost of various training 
institutions were involved, including colleges of 
health sciences, health technology and midwifery 
schools and various professional bodies and their 
registration boards” – (Policy maker)
Stakeholders' perception of evidence 
The respondents described evidence in 
different ways and most respondents' 
perceived evidence to be something factual 
and concrete to support a given decision. This 
is shown by the following quotes' 
“My understanding of evidence use is having 
concrete data that has been collected through a 
process that is considered legitimate and you give 
reference to that data. It could have been a survey.” 
(NGO) 
“[…] evidence is like a mere idea that has been 
harvested and shows where you are, and informs 
what you intend to subsequently do. In this 
context, it should prove there is a situation' 
(Policy-Maker- Legislator) 
Policy makers, especially at the departmental 
and ministerial levels viewed evidence as 
concrete physical evidence of data and 
information garnered from experience of 
experts in a particular eld. A statement 
reecting the opinion of the policy maker says 
“Evidence is something that is feasible, that is 
physical… you can see it… something that you 
prove over a period of time or something that is 
concrete” It could also be something that you have 
experienced” (policymaker-ministry of health) 
Academics perceived evidence to be factual 
information on the specic area that the 
policy is being developed. “The policy process 
and development should be supported by actual 
fact found or issues that you want to address” 
(Academia)
Development partners perceived evidence to 
be veriable information like that obtained 
from primary surveys conducted within the 
c o u n t r y  o r  p u b l i s h e d  n a t i o n a l  a n d 
international data sets and articles to reports 
from stakeholder consultations  
“Evidence am looking more at empirical 
data….empirical data. But beyond looking at 
empirical data, am also interested in the process of 
gathering that data. I think it is the data about the 
people”. (DP) 
Role of Actors 
Actors played diverse roles in the evidence 
process which included production and 
distribution of health workforce registry and 
hiring of consultants who generated the 
evidence. Some actors facilitated and 
coordinated the evidence generation and 
disseminat ion  process .  Whi le  some 
(academics)  appl ied  the ir  technica l 
knowledge to facilitate evidence generation 
and dissemination. Some actors were 
important in coordinating the drafting of the 
policy document.  These actors were 
sometimes in groups or consulted as 
individuals who were in strategic positions. 
The roles of specic actors is shown below; 
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Government policy makers 
Our analysis shows that government 
policymakers played a lead role in the 
development of the HRH policy and three 
branches of the government were involved:  
i. the executive branch ii. the executive branch 
and iii. the civil servants. The directional 
power and mandate of government actors to 
make policies and commission evidence for 
policy development contributed to their high 
inuence on the policy processes.  
Although government played a formal lead 
role in evidence used in HRH policy 
development, its involvement and level of 
power seemed hinged on the presence of a 
policy champion who was at the highest level 
of government and seemed to drive the policy 
development process. In the words of one 
government respondent: 
“Before now there was no track of the Human 
Resources for Health and the minister then 
capitalized on that because he was very serious 
with his health reform agenda in that period. You 
know this country had so many health reforms in 
so many areas during his tenure”. Policy maker 
According to the respondents, two sub-
categories of government were particularly 
active in policy development: i) executive arm 
(e.g. Minister of Health; Federal Executive 
Council); and ii) bureaucrats or civil servants 
in the administrative system (e.g. Permanent 
secretary and Directors in the Ministries and 
Departments). These were often drawn from 
national and state levels of government. 
Policy was developed at national level, with 
the states (i.e. sub-national levels) taking 
responsibility for policy implementation. The 
executive arm of government mainly played 
the role of agenda setting, after which the 
bureaucrats initiated and coordinated the 
process of policy development. 
 “The Federal ministry of health then spearheaded 
a meeting of experts where a technical working 
group was constituted and the decision to gather 
evidence to develop the policy was made.” The 
ministry of health was like the driving engine for 
the whole process. So whatever happens, there is 
high level of ownership of policy document. 
Various training institutions, line ministries, and 
agencies were also involved” - policymaker 
 
Civil society organizations 
Respondents stated that CSOs comprising 
mainstream grass-root non-governmental 
organisa t ions  (NGOs) ,  profess ional 
regulatory boards and councils with close ties 
to the government and registered under 
government regulations, exerted their 
inuence through evidence generation and 
advocacy by acting as pressure groups to 
promote the interests of patients or health 
staff advocating for e.g., improvements in 
healthcare delivery through workforce 
redistribution and recruitment. This is 
evident in the response below  
'But you know, there was a lot of lobbying in 
terms of buying the interest of partner 
organizat ions  and other  CSOs-- - - - - -
professional bodies would lobby. You know 
if they don't do that, then wait for them to 
strike during implementation. (policy maker)
 
Academics 
Academics are public health experts in 
universities and research institutions. The 
respondents  reected that  technical 
competence of academics was the main 
characteristic, which contributed to their 
inuence in evidence and policy processes.  
“Consultants mainly from universities and 
research institutions were hired to do the 
assessment but they worked through the ministry 
of health.” (CSO)
Development partners were involved in both 
the evidence and policy processes. They 
included both bilateral for example; the 
World Bank, Department for International 
Development (DFID) and United States 
Agency for International Development 
(USAID) and multilateral organizations such 
as United Nations International Children's 
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Emergency Fund (UNICEF), WHO and 
PATHS2. A combination of technical 
expertise and nancial power were the key 
characteristics of this group of actors, 
contributing to their roles in evidence and 
policy processes. Multilateral organizations 
such as PATHS2 and WHO, played a key role 
in setting the policy agenda. However all the 
respondents opined that PATHS2 virtually 
spearheaded the development of the HRH 
policy especially the evidence generation 
process where a situation analysis was done.
“Actually PATHS started the move. But then 
remember it was a national agenda. Many 
organizations were already making noise about it, 
but this time PATHS led in the development. So, 
we had support from PATHS and PATHS got 
consultants who led the process.” (policy maker)
Health workers 
These were nurses, doctors, dental and allied 
health practitioners in private and public 
practice who were often represented by their 
professional organizations. In the analysis we 
regarded practitioner and professional 
groups' under health workers as these groups 
often represent the interests of health 
15
workers.  From our observations the role 
played by this group of actors is unclear. 
However their role can be said to be 
contr ibutory as  the heads of  health 
institutions and professional organizations 
were a part of the technical working group. 
The practitioners were more at the service 
delivery level and thus may be involved at the 
policy implementation level. 
The roles played by the various actors 
determined their level of inuence on the 
evidence and policy processes.  Government 
and development partners had identically 
high inuences on policy and evidence 
processes with government initiating, 
coordinating the processes and approving 
policies, while development partners 
provided funding and technical expertise for 
the process, CSOs had a high inuence on the 
evidence and policy processes because of their 
active involvement in evidence generation and 
advocacy. Academics and researchers played a 
medium role, featuring mainly as consultants 
for generating research evidence.  
An individual was identied by our 
respondents as a policy champion who strove 
persistently for  policy change,  thus 
individual interests and value of policy 
champions appear to be important in 
inspiring leadership role in policy processes.
For example, the perceived alignment of the 
personal agenda of the Minister for Health, 
with the health sector reform agenda of the 
country was reported as being a particular 
motivation for developing the HRH policy. 
Despite the international interest  in 
promoting HRH in Nigeria, respondents 
believed the policy would not have been 
formulated without a favourable political 
climate and particularly the personal interest 
of the Minister of health, who took on the role 
17, 18of a policy champion.  These ndings are 
summarized in table 1 below.
Actor roles during policy development are 
not known to be static and levels of inuence 
might change from one phase to another. 
Each group of actors presented in this table, is 
associated with specic characteristics where 
t h e y  h a d  i n  u e n c e d  H R H  p o l i c y 
development the most.
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Table 1: showing actors by their level of power and inuence in policy development process
Power of 
Actors 
Actor Groups Type of influence exerted Relevant quotes 
High Policy Elites Highly influenced evidence 
and policy development. 
Spearheaded the policy and 
evidence processes. Gave 
legal backing and 
endorsement to both 
processes. 
‘The government interest is in the 
reform because if the government 
was not interested in the reform it 
wouldn’t work. So the key 









Concept note development. 
Custodian of HRH data. High 
power to dictate the tone of 
policy development 
‘The leadership of the ministry 
and some of the various 
departments took charge of 
spearheading the proposal. The 







Highly influenced funding to 
generate evidence, pay 
consultants, hold technical 
meetings.
 
‘Financially and technically, 
contributions were mainly from 





 Advocacy:  promoting 




They defend the rights of citizens 
and ensure concrete information 
on distribution of health workers, 
where they are? Whether public or 







 Brought their power of 
knowledge and expertise into 
the evidence process. Were 
invited to the policy process 
because of their technical 
skill
 
‘There was research conducted by 
individuals like lecturers in the 
higher institutions and We 
consulted them and called for 
scientific presentations from them. 
We used their presentations to 





Had power to issue orders but 
never did. Did not influence 
the evidence process and to a 
lesser extent the policy 
process.
  
‘The house of assembly were co -
opted in the process so as to give 
priority to health issues that were 













Had very little influence
 
‘So we had a meeting with t hem, 
in fact a dissemination meeting so 





Not visible in any of the 
processes. Provided 
information on health 
workforce distribution as 
informants
 
They give you information on 
distribution of health workers, 
where they are? Whether public or 
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The arrangement of the table above shows 
that power decreases downwards and those 
actors in the group labelled high were more 
inuential in the policy development process 
than those at the medium and low groups. 
Different actors exhibited different levels of 
inuences and types of power in the evidence 
process. The development partners were very 
inuential, especially in nancing of evidence 
processes and funding of technical meetings. 
The policy elites such as the honourable 
minister of health who was a technocrat used 
his power of position to move the HRH issue 
onto the policy agenda as he was very serious 
with his health reform agenda. The case was 
also similar for senior civil servants and other 
actors within bureaucracy who had powers of 
ofce and positions to direct, produce and 
communicate the evidence. The CSOs had 
high power because their contributions 
seemed indispensable. They were involved in 
evidence generation and seemed to be able to 
produce some evidence on absolute numbers 
and distribution of health workers in the 
country. They also formed a pressure group 
advocating for citizen rights.  Although the 
consultants/academia lacked the power of 
position as well as nancial power to 
inuence the evidence process, their technical 
expertise may have facilitated the most part of 
the process as they were hired as consultants 
to carry out the baseline survey and 
contribute to the policy development process 
as well by using evidence from their 
researches.
DISCUSSION 
The stakeholders involved in developing 
these policies represented different bodies 
within (health care providers) and outside 
(executive and legislative arm) the health 
sector. In Nigeria, like most other countries, 
public policy making is the mandate of 
elected government ofcials or their 
appointees.  These policy makers are 
inuenced by various groups of actors who 
have special interests. These actors who may 
not have the power to make or enforce policy 
themselves, exercise varying levels of 
2 , 1 9
inuence on i ts  process.  This has 
implications on advocacy and dissemination 
of the policies in terms of bringing research 
closer to people and policy making. 
The media makes ideas and ideologies 
stronger and more manifest and their 
participation can be used to advance public 
20, 21
health agendas.  In this study however, the 
role of the media was not felt because their 
usual ability to provide important context for 
facts  in this  policy process was not 
demonstrated. This neglect of the media in 
both processes could imply that the policy 
may not have been disseminated maximally. 
Many of the implementers or recipients of this 
policy were probably unaware of the 
development of this policy. This alone could 
affect the success of policy implementation 
and uptake negatively.
The medium involvement of the academia 
a n d  r e s e a r c h e r s  s h o w  i n s u f  c i e n t 
representation of this group during the policy 
development. The results show they were 
more active during the evidence generation 
stage. This will contribute further to the 
apparent disconnect between policy makers 
and researchers, making research uptake 
more difcult. The academia are well 
informed and would reasonably be expected 
to facilitate communication and sharing of 
information among key stakeholders, policy-
makers and end users at every stage of the 
policymaking process. The fact that there 
were active CSO networking was a positive 
nding, because active group and individual 
engagement in policy making is an important 
factor for producing a successful policy 
19document.
The presence of a collaborative environment 
formed through the development of dynamic 
n e t w o r k s  i n v o l v i n g  p o l i c y - m a k e r s , 
researchers, users and representatives from 
civil society who meet around well-dened 
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issues of concern to policy-makers gives 
credibility to the process. The interplay of 
power among actors to inuence the policy 
process was a very dynamic one. The power 
play though perceived as mainly positive 
would have been fraught with tensions 
between the actors as they each sought to 
have greater inuence on the process. 
Similarly the inuence and interplay of 
power in policy process as well as actor 
relationships has also been illustrated in other 
22, 23studies.
The decision to formulate policy from 
available evidence was largely dependent on 
t h e  i d e o l o g i e s  a n d  c o m m i t m e n t  o f 
g o v e r n m e n t  a n d  t h e  s t a k e h o l d e r s ' 
spearheading and developing the policies. 
These individuals can be called policy 
champions because they are instrumental to 
implementing a change process and ensuring 
17
the use of evidence to inuence policy change.  
Respondents mainly referred to the policy 
champion as an individual, however 
individuals often represent organizations 
a n d  t h e s e  o r g a n i s a t i o n s  a n d  i n t e r -
organizational relationships are likely to 
18
affect their roles to inuence policy process.  
Policy-makers and researchers work in 
different environments. This difference 
becomes important as they express their 
experiences and their varying perspectives on 
use of knowledge and information in policy 
making, thereby producing a rich policy. The 
policies were developed by capturing most 
participants' contribution towards the 
development of the documents and each 
person's view was a reection of their 
perception of the problem. Since policies are 
made to shape and manage people's 
behaviour, involving those groups of people 
affected by policy is important in the policy 
24
formulation process.  
STUDY LIMITATIONS 
This study did not capture the use of evidence 
in the implementation of the HRH policy.  
CONCLUSION 
The types of evidence used in formulating the 
HRH policy are determined by the ideologies 
of the most powerful actors as well as their 
political leanings. The role an actor played in 
the evidence and policy process determined 
the inuence wielded by the actor in the nal 
stages of policy development. Policy-making 
increasingly requires interaction between 
stakeholders to provide solutions based on 
consensus models even after research 
evidence. Researchers and academia do not 
generally operate under such restrictions and 
act only based on documented evidence. This 
apparent disconnect between the way 
academia and policy makers think will make 
uptake of research ndings alone more 
difcult by policy makers. 
Government policy makers, especially the 
executive arm had the power of authority and 
coercion and so had a high inuence and 
drove the policy process.  Financial power 
and group power also give actors an added 
advantage and high inuence during the 
policy development process, as in the case of 
the development partners and the civil 
society organizations. 
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